Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,115 | -1,487 | -1,018 | -540 | -2,592 |
| Depreciation Amortization | 216 | 122 | 89 | 53 | 8 |
| Other Working Capital | 1,437 | 1,109 | 689 | 364 | 1,848 |
| Other Operating Activity | -25 | -57 | -26 | -15 | 308 |
| Operating Cash Flow | $-488 | $-314 | $-266 | $-138 | $-427 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 478 | 25 | 25 | 110 | 80 |
| Debt Issued | 23 | 264 | 214 | N/A | 100 |
| Common Stock Issued | N/A | N/A | -6 | N/A | 196 |
| Other Financing Activity | -30 | -8 | 0 | 0 | 0 |
| Financing Cash Flow | $471 | $281 | $233 | $110 | $376 |
| Beginning Cash Position | 33 | 33 | 33 | 33 | 85 |
| End Cash Position | 17 | 0 | 0 | 6 | 33 |
| Net Cash Flow | $-17 | $-33 | $-33 | $-28 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -488 | -314 | -266 | -138 | -427 |
| Free Cash Flow | -488 | -314 | -266 | -138 | -427 |